Reasons and Determinants of BoNT-A Treatment Discontinuation in Patients Living with Spasticity: A 10-Year Retrospective Analysis

Reasons and Determinants of BoNT-A Treatment Discontinuation in Patients Living with Spasticity: A 10-Year Retrospective Analysis

Background: The present study aimed to evaluate the reasons and determinants of BoNT-A discontinuation in patients with stroke, multiple sclerosis, spinal cord injury, and traumatic brain injury. Methods: It is a retrospective study of 56 discontinuer patients treated with botulinum toxin between Ja...

Full description

Bibliographic Details
Main Authors:	Nicoletta Cinone, Luigi Santoro, Stefania Spina, Salvatore Facciorusso, Marco Battaglia, Alessio Baricich, Pasqua Marcogiuseppe, Andrea Santamato
Format:	Article
Language:	English
Published:	MDPI AG 2022-09-01
Series:	Toxins
Subjects:	botulinum toxin spasticity discontinuation
Online Access:	https://www.mdpi.com/2072-6651/14/10/675

Similar Items

BoNT-A for Post-Stroke Spasticity: Guidance on Unmet Clinical Needs from a Delphi Panel Approach
by: Alessio Baricich, et al.
Published: (2021-03-01)

Adjunctive treatment and BoNT-A for post-stroke spasticity: Are we really focusing on the patient-centered goals?
by: Alessio Baricich, et al.
Published: (2023-03-01)

Combined Effects of Isokinetic Training and Botulinum Toxin Type A on Spastic Equinus Foot in Patients with Chronic Stroke: A Pilot, Single-blind, Randomized Controlled Trial
by: Nicoletta Cinone, et al.
Published: (2019-04-01)

The use of botulinum toxin (BoNT) in urology - review
by: Jakub Szwed, et al.
Published: (2022-08-01)

Triceps Surae Muscle Characteristics in Spastic Hemiparetic Stroke Survivors Treated with Botulinum Toxin Type A: Clinical Implications from Ultrasonographic Evaluation
by: Marco Battaglia, et al.
Published: (2021-12-01)

Early Botulinum Toxin Type A Injection for Post-Stroke Spasticity: A Longitudinal Cohort Study
by: Alessandro Picelli, et al.
Published: (2021-05-01)

Botulinum toxin (BoNT) in the correction of mimic wrinkles - the most common complications
by: Monika Szwed, et al.
Published: (2022-08-01)

Spasticity Treatment During COVID-19 Pandemic: Clinical Recommendations
by: Alessio Baricich, et al.
Published: (2020-06-01)

A Review of the Efficacy of Botulinum Toxin in Spasticity Reduction in Upper and Lower Extremities and Gait improvement in Individuals with Stroke
by: Saede Shahriarpour, et al.
Published: (2016-03-01)

High Dosage of Botulinum Toxin Type A in Adult Subjects with Spasticity Following Acquired Central Nervous System Damage: Where Are We at?
by: Domenico Intiso, et al.
Published: (2020-05-01)

Clinical efficacy of botulinum toxin type A in patients with traumatic brain injury, spinal cord injury, or multiple sclerosis: An observational longitudinal study
by: Alessio Baricich, et al.
Published: (2023-04-01)

The Evaluation of Botulinum Toxin Injection Effect for Poststroke Spasticity Treatment
by: Bekir Enes Demiryurek, et al.
Published: (2017-03-01)

Rectus Femoris Characteristics in Post Stroke Spasticity: Clinical Implications from Ultrasonographic Evaluation
by: Lucia Cosenza, et al.
Published: (2020-07-01)

The Efficacy of Botulinum Toxin A Intramuscular Injections in After-Stroke Spasticity
by: Melek Karaçam, et al.
Published: (2010-09-01)

The Efficacy of Botulinum Toxin A Intramuscular Injections in After-Stroke Spasticity
by: Melek Karaçam, et al.
Published: (2010-09-01)

High Doses of Botulinum Toxin Type A for the Treatment of Post-Stroke Spasticity: Rationale for a Real Benefit for the Patients
by: Andrea Santamato
Published: (2022-05-01)

A Novel Catalytically Inactive Construct of Botulinum Neurotoxin A (BoNT/A) Directly Inhibits Visceral Sensory Signalling
by: Hodan Ibrahim, et al.
Published: (2024-01-01)

Navigating the Complexities Involving the Identification of Botulinum Neurotoxins (BoNTs) and the Taxonomy of BoNT-Producing Clostridia
by: Theresa J. Smith, et al.
Published: (2023-09-01)

Subcutaneous BoNT/A Injection for Intractable Pain and Disability in Complex Regional Pain Syndrome: A Case Report
by: Yan Tereshko, et al.
Published: (2022-06-01)

Treatment of the Spasticity in Children with Cerebral Palsy
by: Ajša Meholjić-Fetahović
Published: (2008-11-01)

Pharmacotherapy of Spasticity in Children With Cerebral Palsy
by: Chia-Ying Chung, et al.
Published: (2011-04-01)

A literature review on the efficacy and safety of botulinum toxin: An injection in post-stroke spasticity
by: Majid Ghasemi, et al.
Published: (2013-01-01)

The Lack of Systemic and Subclinical Side Effects of Botulinum Neurotoxin Type-A in Patients Affected by Post-Stroke Spasticity: A Longitudinal Cohort Study
by: Marco Battaglia, et al.
Published: (2022-08-01)

A practical guide to optimizing the benefits of post-stroke spasticity interventions with botulinum toxin A: An international group consensus
by: Gerard E. Francisco, et al.
Published: (2021-01-01)

Recombinant Botulinum Neurotoxin Hc Subunit (BoNT Hc) and Catalytically Inactive Clostridium botulinum Holoproteins (ciBoNT HPs) as Vaccine Candidates for the Prevention of Botulism
by: Robert P. Webb, et al.
Published: (2017-09-01)

Botulinum toxin type A in treatment of chronic migraine, spasticity and bruxism
by: Klaudia Kuliga, et al.
Published: (2023-05-01)

Canadian Physicians’ Use of Intramuscular Botulinum Toxin Injections for Shoulder Spasticity: A National Cross-Sectional Survey
by: Farris Kassam, et al.
Published: (2023-01-01)

Treatment for poststroke spasticity, the use of mydocalm
by: V. A. Parfenov
Published: (2011-09-01)

Comparison of botulinum toxin (BoNT) injection and lateral internal sphincterotomy (redo-LIS) for recurrent anal fissure treatment
by: Ahmet Alyanak, et al.
Published: (2022-09-01)

Effect of BoNT/A in the Surface Electromyographic Characteristics of the Pelvic Floor Muscles for the Treatment of Chronic Pelvic Pain
by: Monica Albaladejo-Belmonte, et al.
Published: (2021-07-01)

BoNT/A1 Secondary Failure for the Treatment of Neurogenic Detrusor Overactivity: An Ex Vivo Functional Study
by: Jacquie Maignel, et al.
Published: (2022-01-01)

Emerging Concepts and Evidence in Telematics Novel Approaches or Treatments for Spasticity Management After Botulinum Injection
by: Helena Bascuñana-Ambrós, et al.
Published: (2021-09-01)

Management of Upper-Limb Spasticity Using Modern Rehabilitation Techniques versus Botulinum Toxin Injections Following Stroke
by: Ana Maria Bumbea, et al.
Published: (2023-11-01)

A systematic review: efficacy of botulinum toxin in walking and quality of life in post-stroke lower limb spasticity
by: Anupam Datta Gupta, et al.
Published: (2018-01-01)

ULIS (Upper Limb International Spasticity), a 10-year Odyssey: An international, multicentric, longitudinal cohort of person-centered spasticity management in real-life practice
by: Lynne Turner-Stokes, et al.
Published: (2019-01-01)

Treatment for spasticity after stroke
by: S. E. Khatkova
Published: (2010-09-01)

Ankle and Foot Spasticity Patterns in Chronic Stroke Survivors with Abnormal Gait
by: Sheng Li
Published: (2020-10-01)

POSTSTROKE SPASTICITY: AN INDIVIDUALIZED APPROACH TO TREATMENT
by: V. A. Tolmacheva
Published: (2016-12-01)

Health-Related Quality of Life Outcomes from Botulinum Toxin Treatment in Spasticity
by: Lorenzo Pietro Roncoroni, et al.
Published: (2020-05-01)

Stiff Knee Gait Disorders as Neuromechanical Consequences of Spastic Hemiplegia in Chronic Stroke
by: Sheng Li
Published: (2023-03-01)